Peptide Therapy in Boise Specialized Treatment for First Responders Blueline Wellness In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for Peptides Lack Reliable Safety Information, Watchdog Warns Early evidence suggests BPC 157 repairs tissue rather than just dulling symptoms. To read more, tap the link in bio. RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,